In vivo epigenetic editing of Sema6a promoter reverses transcallosal dysconnectivity caused by C11orf46/Arl14ep risk gene

Cyril Peter(Allen Institute for Brain Science), Atsushi Kamiya(Johns Hopkins University)
Nature Communications
September 11, 2019
Cited by 57


Related Papers